Patented Medicine Prices Review Board Rules of Practice and Procedure, SOR/2012-247
Section 1
Cite as Patented Medicine Prices Review Board Rules of Practice and Procedure, SOR/2012-247, s. 1 · current to July 24, 2025 · regulation last amended June 30, 2021
Statute Watch
Get an alert when a bill in Parliament would change this section, and every time it moves.
The text
The definitions in this section apply in these Rules.
Act means the Patent Act. (Loi)
Chairperson means the Chairperson of the Board designated under subsection 93(1) of the Act. (président)
concerned minister means a federal Minister or a provincial minister referred to in subsection 86(2) of the Act, as the context requires. (ministre intéressé)
counsel means a member of the bar of a province. (conseiller juridique)
hearing includes a conference held under these Rules. (audience)
party means
(a) a respondent;
(b) Board Staff;
(c) a concerned minister; or
(d) a person who has been granted leave to intervene under Rule 20. (partie)
person includes an unincorporated organization or entity. (personne)
respondent means a rights holder, or a former rights holder, against whom an order of the Board is proposed to be made under the Act. (intimé)
Secretary means the Director of Board Secretariat or anyone acting on her or his behalf. (secrétaire)
Read the Patented Medicine Prices Review Board Rules of Practice and Procedure on the Justice Laws Website ↗
Made under Patent Act, R.S.C. 1985, c. P-4.
Bills in Parliament that would change this section 0
No bill we hold would amend or repeal this section.